Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02086890 · ClinicalTrials.gov registry record · NA

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa

A NA study of Retinitis Pigmentosa, sponsored by Nova Southeastern University.

Active
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT02086890 is a NA study of Retinitis Pigmentosa that is active but no longer recruiting, run by Nova Southeastern University. The registered enrollment target is 21 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02086890, a NA study of Retinitis Pigmentosa, is active but no longer recruiting, sponsored by Nova Southeastern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

Measures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.

Conditions Studied

Interventions

  • DEVICE Electro-acupuncture
  • DEVICE Laser Acupuncture
  • DEVICE Transcorneal Electrical Stimulation
  • DEVICE Sham Electro-acupuncture
  • DEVICE Sham laser acupuncture

Study Locations (1)

Florida

  • Nova Southeastern University; College of Optometry - Fort Lauderdale

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-08-13
Est. Completion 2027-12
Phase NA

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT02086890

The ClinicalTrials.gov registry entry for NCT02086890 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (92% lower). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 5 interventions - of which Electro-acupuncture is the first listed.

NCT02086890 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02086890 about?

NCT02086890 is a clinical study titled "Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa". Measures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.

What is the current status of trial NCT02086890?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2014-08-13. Estimated completion is 2027-12.

What conditions does trial NCT02086890 study?

This clinical trial studies the following conditions: Retinitis Pigmentosa.

What interventions are being tested in trial NCT02086890?

The interventions under investigation include: Electro-acupuncture (DEVICE), Laser Acupuncture (DEVICE), Transcorneal Electrical Stimulation (DEVICE), Sham Electro-acupuncture (DEVICE), Sham laser acupuncture (DEVICE).

Who is sponsoring clinical trial NCT02086890?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02086890 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.